Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+68.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+68.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.8x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 107.97% |
| 2024 | -353.49% |
| 2023 | -69.63% |
| 2022 | 22.62% |
| 2021 | 1.32% |
| 2020 | -37.73% |
| 2019 | -62.21% |
| 2018 | -17.50% |
| 2017 | 10.57% |
| 2016 | -11.93% |